Generic Partners Pty Ltd v Neurim Pharmaceuticals Ltd

Generic Partners Pty Ltd sought an extension of time for the opposition to a patent application. Neurim Pharmaceuticals Ltd opposed the application on the grounds that the extension should not be granted. The Federal Court of Australia was the venue for this case. The primary legal issue was whether the extension of time could be granted under section 223 of the Patents Act 1990, considering that the application was made outside the prescribed time limit, and if so, whether the error or omission was causative to frustrate the intention of filing the opposition within the prescribed time.

The court considered whether section 223 was applicable to the extension of time for oppositions under section 24. It concluded that section 223 was indeed applicable, as it provided a grace period for errors or omissions. The court further determined that there was an error or omission in the filing of the opposition, as the applicant had not provided specific details required by the rules. This error or omission was found to be causative, as it prevented the opposition from being filed within the prescribed time limit.

The court exercised its discretion under section 223 to grant the extension of time for the opposition. The decision was based on the finding that the error or omission was significant and that granting the extension would not prejudice the patent holder. The court also awarded costs against the opponent, Neurim Pharmaceuticals Ltd, as the extension application was successful.